Streetbeat News

Products Services

CLNN

Clene Inc (NASDAQ:CLNN) reported new data showing a significant reduction in plasma neurofilament light chain (NfL) levels for CNM-Au8 treated participants compared to placebo after 24 weeks in the HEALEY ALS Platform Trial. Clene also raised $40 million through an underwritten public offering of 50 million shares and two tranches of warrants at a combined price of $0.80.

Portfolio Pulse from Vandana Singh

June 16, 2023 | 5:55 pm

MRK

Merck announced positive topline data from the Phase 3 KEYNOTE-811 trial of Keytruda plus trastuzumab and chemotherapy for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma. The study met one of its dual primary endpoints of progression-free survival (PFS). Merck is working with the FDA to update the current indication for Keytruda in HER2-positive gastric or GEJ adenocarcinoma to those patients whose tumors are PD-L1 positive.

Portfolio Pulse from Vandana Singh

June 16, 2023 | 5:50 pm

LLY

PFE

Eli Lilly's Emgality failed to meet the primary endpoint in a head-to-head study with Pfizer's Nurtec ODT for migraine treatment. Emgality did not show statistical superiority in reducing monthly migraine headache days by 50% or more. Pfizer acquired Nurtec ODT after buying Biohaven Pharmaceutical for $11.6 billion.

Portfolio Pulse from Vandana Singh

June 16, 2023 | 5:48 pm

CURLF

22Red, a cannabis brand co-founded by Shavo Odadjian, has launched four new strains of indoor-grown flower in Arizona. The strains are available exclusively at Curaleaf (OTC:CURLF) locations in the state.

Portfolio Pulse from Javier Hasse

June 16, 2023 | 5:36 pm

SIDU

Sidus Space will be issued U.S. Patent Number 11,679,366 on Tuesday for its vacuum chamber, feedthrough system for vacuum chamber, and related methods. This patent could potentially strengthen the company's intellectual property portfolio.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:25 pm

LLY

Eli Lilly announced results of the CHALLENGE-MIG clinical trial of Emgality in episodic migraine prevention, which did not achieve statistical superiority versus active comparator Nurtec ODT on the primary endpoint. However, Emgality demonstrated robust efficacy and performed numerically better on key secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 4:04 pm

META

Meta Platforms CEO Mark Zuckerberg introduced Voicebox, an advanced AI text-to-speech model that can produce realistic, contextually accurate speech output. Voicebox is built on a foundation of non-autoregressive flow-matching model and trained on over 50,000 hours of diverse audio in multiple languages.

Portfolio Pulse from AJ Fabino

June 16, 2023 | 3:59 pm

COIN

Coinbase Global Inc (NASDAQ:COIN) has launched a 4% rewards program for USD Coin (CRYPTO: USDC) despite ongoing scrutiny from the U.S. Securities and Exchange Commission (SEC). The program aims to encourage users to expand their funds and explore the cryptocurrency ecosystem.

Portfolio Pulse from Murtuza Merchant

June 16, 2023 | 3:54 pm

TCNNF

The Georgia State Board of Pharmacy has released regulations allowing independent pharmacies to sell cannabis oil to registered patients. Over 100 pharmacies have expressed interest in selling the product. The state's licensed producers, Botanical Sciences LLC and Trulieve Cannabis Corp. (OTCQX:TCNNF), will supply the pharmacies.

Portfolio Pulse from Jelena Martinovic

June 16, 2023 | 3:47 pm

LAES

WKEY

WISeKey International Holding Ltd and its semiconductors subsidiary SEALSQ Corp have developed an AI-based quantum solutions demonstrator for post-quantum cryptography. This marks a significant milestone for the QUASARS project and brings the company closer to building a Post-Quantum Hardware Security Module.

Portfolio Pulse from Nabaparna Bhattacharya

June 16, 2023 | 3:47 pm